We can isolate pure, in-tact, and viable exosomes from any biofluid. Our platform can isolate any exosome subtype, is scalable, and can accommodate nearly any volume of input. Alternative isolation methods are time-consuming, skill-intensive, and result in noisy, heterogeneous outputs.

Clara Biotech solves these problems and enables tomorrow’s medical breakthroughs today with our patented technology which physically detaches exosomes from the affinity bead complex without compromising viability or structural integrity in a non-chemical release process, preventing contamination from junk RNA, DNA, or proteins resulting in truly pure and functional exosomes.

The ExoRelease™ platform offers a uniquely pure, novel, high specificity solution with high yield and quality. Stop waiting on the centrifuge. Send us your samples and we’ll get them back to you quickly. Our services are tailored uniquely to each individual’s needs and budget.